STOK•benzinga•
HC Wainwright & Co. Maintains Buy on Stoke Therapeutics, Lowers Price Target to $35
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 14, 2025 by benzinga